Physician profile
Frederick J Kaskel
NPI 1699851535
$19,455.63
in general payments reported to CMS, 2019-2025
6 companies · $4,345 in 2025
The $4,345 reported for 2025 was more than what 86% of Pediatric Nephrology providers received nationally (typical 2025 total: $131).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.06 · 2021: $15.37 · 2023: $5,979 · 2024: $9,068 · 2025: $4,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Honoraria: $4,587 · Travel and Lodging: $2,823 · Food and Beverage: $644.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,338.00 |
| Honoraria | $4,587.00 |
| Travel and Lodging | $2,822.86 |
| Food and Beverage | $644.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $9,068.00 | 2024 | Procysbi |
| Horizon Therapeutics Plc | $5,978.91 | 2023 | Tepezza, Procysbi |
| Travere Therapeutics, INC. | $4,248.63 | 2025 | Filspari |
| Novartis Pharmaceuticals Corporation | $96.66 | 2025 | |
| Alexion Pharmaceuticals, INC. | $48.06 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Kaskel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.